Astonea Labs Limited has scheduled its 9th Annual General Meeting (AGM) for August 21, 2026, to seek shareholder approval for significant strategic expansions, including alterations to its Memorandum of Association and the incorporation of new subsidiary companies. The meeting will be held in physical mode at Mercure Hotel in Chandigarh, where members will also vote on the re-appointment of Director Ms. Pooja Singh and the ratification of cost auditor remuneration.

The Board of Directors approved the notice for the AGM on July 24, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Section 102 of the Companies Act, 2013. The company is providing remote e-voting facilities through National Securities Depository Limited (NSDL), with the voting window open from August 18 to August 20, 2026. The cut-off date for determining eligibility for voting is August 14, 2026.

Key Resolutions

The AGM agenda comprises three ordinary businesses and three special resolutions. The most material items involve structural changes to facilitate future growth:

Strategic Expansion via MOA Amendment

The proposed alteration to the Object Clause of the Memorandum of Association aims to align the company’s legal framework with its growth strategy. The amendment will explicitly permit Astonea Labs to manufacture, formulate, process, and trade a wider range of products, including antibiotics, biologicals, vaccines, ayurvedic products, and dietary supplements. Furthermore, it enables the company to utilize diverse commercial channels such as e-commerce platforms, digital marketplaces, and franchise arrangements for distribution. This flexibility is intended to support long-term business objectives without adversely affecting member or creditor rights.

Subsidiary Investments

Shareholders are also being asked to approve the incorporation and investment in subsidiary companies in India. This resolution provides the Board with the authority to promote and subscribe to share capital in new entities to create focused business verticals and achieve operational efficiencies. The company noted that an aggregate investment limit of ₹100 crore was previously approved by members at an Extra-Ordinary General Meeting held on March 27, 2026, under Section 186 of the Companies Act, 2013.

Meeting Logistics

The register of members and share transfer books will remain closed from August 15 to August 21, 2026, for the purpose of the AGM. Members holding shares in physical form are advised to ensure their KYC details are updated with the Registrar and Transfer Agent, KFin Technologies Ltd. The scrutinizer for the e-voting process is Mr. Sahil Malhotra (Membership No. A38204).

Astonea Labs Limited submitted its Annual Report for the financial year ended March 31, 2026, to BSE Limited on July 24, 2026. This filing fulfills the company’s regulatory disclosure obligations under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The submission ensures shareholders have access to the company’s audited financial performance and governance updates for FY26.

The filing was made pursuant to Regulation 34(1) and other applicable provisions of the SEBI Listing Regulations. Ankit Kapoor, Company Secretary and Compliance Officer, signed the submission on behalf of the company. The document confirms that the Annual Report has been approved by the Board of Directors at its meeting held on July 24, 2026.

Report Contents

The Annual Report comprises several key documents required under the Companies Act, 2013, and related rules:

The report also includes other statements and information mandated by applicable statutory requirements. It will be circulated to members in accordance with the law.

Corporate Details

Astonea Labs Limited, formerly known as Astonea Labs Private Limited, is registered with CIN L24304CH2017PLC041482. The company operates from its corporate office in Panchkula, Haryana, with a plant located in Village Haripur, Distt. Panchkula. Its registered office is situated in Chandigarh.

The filing requests that BSE Limited take cognizance of the submission for its information and records. No specific financial metrics such as revenue or net profit were detailed in this cover letter; those figures are contained within the enclosed Annual Report.